IRIS
CARLO STELLA, CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.653
AS - Asia 6.770
EU - Europa 2.097
SA - Sud America 1.189
AF - Africa 312
Continente sconosciuto - Info sul continente non disponibili 253
OC - Oceania 14
Totale 22.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.373
SG - Singapore 4.409
CN - Cina 977
BR - Brasile 961
VN - Vietnam 646
IT - Italia 483
FI - Finlandia 372
DE - Germania 258
IE - Irlanda 253
NG - Nigeria 207
HK - Hong Kong 203
FR - Francia 167
CA - Canada 153
GB - Regno Unito 137
IN - India 101
NL - Olanda 80
AR - Argentina 70
MX - Messico 70
BD - Bangladesh 57
TR - Turchia 55
RU - Federazione Russa 52
IQ - Iraq 48
SE - Svezia 45
EC - Ecuador 36
ES - Italia 33
CZ - Repubblica Ceca 31
PK - Pakistan 30
IL - Israele 28
CL - Cile 27
PL - Polonia 27
UA - Ucraina 27
BE - Belgio 25
ID - Indonesia 25
CO - Colombia 24
ZA - Sudafrica 22
PY - Paraguay 21
JP - Giappone 20
SA - Arabia Saudita 19
UZ - Uzbekistan 19
VE - Venezuela 19
LT - Lituania 18
MA - Marocco 18
PH - Filippine 16
AT - Austria 15
EG - Egitto 15
PE - Perù 15
JO - Giordania 13
KE - Kenya 13
MY - Malesia 12
NP - Nepal 12
RO - Romania 12
TN - Tunisia 12
UY - Uruguay 12
JM - Giamaica 11
AU - Australia 10
CR - Costa Rica 9
DO - Repubblica Dominicana 9
AZ - Azerbaigian 8
GR - Grecia 8
IR - Iran 8
A2 - ???statistics.table.value.countryCode.A2??? 7
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
CH - Svizzera 7
DZ - Algeria 7
HN - Honduras 7
KR - Corea 7
TT - Trinidad e Tobago 7
DK - Danimarca 6
TH - Thailandia 6
AM - Armenia 5
ET - Etiopia 5
LK - Sri Lanka 5
LV - Lettonia 5
SY - Repubblica araba siriana 5
GT - Guatemala 4
HR - Croazia 4
KZ - Kazakistan 4
LB - Libano 4
NO - Norvegia 4
OM - Oman 4
SN - Senegal 4
BO - Bolivia 3
GE - Georgia 3
HU - Ungheria 3
MD - Moldavia 3
PS - Palestinian Territory 3
PT - Portogallo 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
KH - Cambogia 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
Totale 22.017
Salva come PNG Salva come JPEG
Città #
Singapore 2.000
Wilmington 1.325
Chandler 1.274
Ashburn 1.057
The Dalles 687
Dallas 622
San Jose 511
San Mateo 505
Shanghai 482
Helsinki 366
Council Bluffs 348
Ann Arbor 334
Dublin 253
Leawood 244
Boardman 237
Princeton 228
Lawrence 227
Benin City 207
New York 207
Hong Kong 195
Ho Chi Minh City 190
Milan 189
Beijing 175
Hanoi 161
Santa Clara 134
Fairfield 124
Paris 123
Los Angeles 121
Woodbridge 96
Rome 80
São Paulo 80
Toronto 79
Amsterdam 75
London 66
Columbus 65
Phoenix 57
Seattle 57
Buffalo 56
Da Nang 40
San Diego 36
Rio de Janeiro 32
Chicago 29
Montreal 28
Munich 28
Norwalk 28
Falls Church 26
Naples 26
Brussels 25
Orem 25
Brooklyn 24
Brasília 23
Brno 23
Falkenstein 22
Warsaw 22
Haiphong 21
Belo Horizonte 20
Houston 20
Tashkent 19
Atlanta 18
Frankfurt am Main 18
Arizona City 17
Bar Harbor 17
Campinas 17
Charlotte 17
Curitiba 16
Figino 16
Philadelphia 16
San Francisco 16
Can Tho 15
Dhaka 15
Guayaquil 15
Kocaeli 15
Biên Hòa 14
Chennai 14
Mexico City 14
Stockholm 14
Amman 13
Baghdad 13
Boston 13
Cincinnati 13
Denver 13
Miami 13
Monmouth Junction 13
Moscow 13
Newark 13
Pune 13
Richmond 13
Tokyo 13
Gunzenhausen 12
Turin 12
Washington 12
Istanbul 11
Johannesburg 11
Nuremberg 11
Redmond 11
Vienna 11
Ankara 10
Asunción 10
Hillsboro 10
Hải Dương 10
Totale 14.325
Salva come PNG Salva come JPEG
Nome #
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis 180
Primary refractory and early-relapsed Hodgkin's lymphoma : strategies for therapeutic targeting based on the tumour microenvironment 162
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogenic stem call transplantation from a HLA identical sibling 161
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®) 150
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH) 147
American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma 140
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 134
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNA 126
ACQUIRED CYCLIC THROMBOCYTOPENIATHROMBOCYTOSIS WITH PERIODIC DEFECT OF PLATELET-FUNCTION 125
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 121
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K delta/gamma Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study 120
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 120
A case of acute myeloid leukemia, with pseudo-Pelger neutrophils 116
High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant 113
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome 111
D Quantification of Tumor Vasculature in Lymphoma Xenografts in NOD/SCID Mice Allows to Detect Differences among Vascular-Targeted Therapies 108
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation 107
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma 106
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 106
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 105
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 105
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma 104
Tumor-derived PGD2 and NKp30 –B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 101
Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation 100
Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis 100
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma 100
Amifostine (WR-2721) selective protection against melphalan genotoxicity 99
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed 99
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial 99
Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses 97
"Overshoot" phenomenon in circulating granulocytic progenitor cell growth during remission of blast crisis in a case of CML 97
Therapeutic relevance of CD34+ cell dose in blood cell transplantation for cancer therapy 97
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection 97
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice 96
Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells 95
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes 95
[Mesenchymal stem cells: biology and clinical applications] 93
Detection of maternal progenitor cells in human umbilical cord blood by single-colony karyotyping 92
Relapse after glofitamab, a novel unmet medical need with high rates of CD20 loss 91
Radioimmunotherapy and secondary leukemia : a case report 91
Cell therapy: achievements and perspectives 91
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade? 91
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 91
Deep learning and atlas-based models to streamline the segmentation workflow of total marrow and lymphoid irradiation 90
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma : a single institution experience 90
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection 90
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 90
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment 89
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia 89
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-a: evidence for a tyrosine-kinase-dependent process 88
AUTOLOGOUS TRANSPLANT FOR CHRONIC MYELOGENOUS LEUKEMIA USING MARROW TREATED EX-VIVO WITH MAFOSFAMIDE 88
EFFECT OF RECOMBINANT GAMMA-INTERFERON ON THE PROLIFERATIVE ACTIVITY OF CULTURED LEUKEMIC-CELLS 87
Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients 87
HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL) 87
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts 86
Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma 86
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery 86
Specific histone patterns and acetylase/deacetylase activity at the breakpoint-cluster region of the human MLL gene 86
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 86
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells 86
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients 85
EFFECT OF RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA ON HUMAN-BONE MARROW DERIVED MEGAKARYOCYTIC PROGENITOR CELLS 84
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia : evidence for premature aging of the myeloid compartment 84
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma 84
Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide 84
UMBILICAL-CORD BLOOD AS A SOURCE OF HEMATOPOIETIC STEM-CELLS - FROM RESEARCH TO CLINIC 83
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma 83
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunological responses in indolent B-cell lymphoma patients with relapsed and measurable disease : a pilot study 83
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma 82
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors : mature results of an Italian randomized phase II study 82
INVITRO MEGAKARYOCYTOPOIESIS IN PATIENTS WITH HIV-RELATED THROMBOCYTOPENIC PURPURA 82
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors. 82
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 82
BIOLOGICAL ASPECTS AND CLINICAL-APPLICATIONS OF LONG-TERM BONE-MARROW CULTURE - A MEETING REPORT 81
Autophagy as a pathogenic mechanism and drug target in lymphoproliferative disorders 81
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases 81
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma 81
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts 81
ESTABLISHMENT OF 2 EPSTEIN-BARR VIRUS NEGATIVE BURKITT CELL-LINES FROM A PATIENT WITH AIDS AND B-CELL LYMPHOMA 80
Peripheral Blood Stem Cells versus Bone Marrow for T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma 80
Stem cells and stem cell transplantation 80
The novel PI3K-ò inhibitor TGR-1202 enhances brentuximab vedotin-induced Hodgkin lymphoma cell death via mitotic arrest. 80
The parallel between CD45 expression and extra-medullary evolution in aggressive myeloma with high serum lactate dehydrogenase 80
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells 80
Stem cell manipulation: why and how performing peripheral blood progenitor cell purging 79
Ex vivo manipulation of hematopoietic stem cells for transplantation: The potential role of amifostine 78
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma 78
The anti-HLA-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing NOD/SCID mice 78
B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY 78
Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation : results from a named patient program at four Italian centers 78
Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and Outcomes 78
Transforming growth factor beta(3) inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis 78
CD34-POSITIVE CELLS - BIOLOGY AND CLINICAL RELEVANCE 77
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen) 77
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias 77
Phase II study of sorafenib in patients with relapsed or refractory lymphoma 77
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (mTRAIL) 77
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA 76
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 76
YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation 76
Totale 9.473
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.033
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.216 0 5 19 277 19 20 30 165 132 193 288 68
2022/20233.410 489 104 294 416 327 293 0 311 609 282 237 48
2023/20241.832 139 219 337 41 32 128 69 133 24 37 282 391
2024/20253.391 88 66 33 69 85 329 197 405 538 805 404 372
2025/20268.443 1.250 462 642 745 234 331 2.509 465 468 500 307 530
2026/20271.647 778 869 0 0 0 0 0 0 0 0 0 0
Totale 22.288